Advanced search
Publication Cover
Therapeutics and Clinical Risk Management Volume 14, 2018 - Issue
Submit an article Journal homepage
68
Views
9
CrossRef citations to date
0
Altmetric
Review

Benralizumab, an add-on treatment for severe eosinophilic asthma: evaluation of exacerbations, emergency department visits, lung function, and oral corticosteroid use

Diego Jose Maselli1 Division of Pulmonary Diseases and Critical Care, University of Texas Health, San Antonio, TX, USA, [email protected]Correspondence[email protected]
,
Linda Rogers2 Division of Pulmonary, Critical Care and Sleep Medicine, Department of Medicine Mount Sinai – National Jewish Health Respiratory Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA
&
Jay I Peters1 Division of Pulmonary Diseases and Critical Care, University of Texas Health, San Antonio, TX, USA, [email protected]
Pages 2059-2068 | Published online: 23 Oct 2018

Citations (9)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (2)

Lauri Lehtimäki, Monica Arvidsson, Bora Erdemli, Cassandra Nan, Tra-My Nguyen, Aditya Samant & Gunilla Telg. (2022) Regional variation in intensity of inhaled asthma medication and oral corticosteroid use in Denmark, Finland, and Sweden. European Clinical Respiratory Journal 9:1.
Read now
Garry M. Walsh. (2020) Anti-IL-5 monoclonal antibodies for the treatment of asthma: an update. Expert Opinion on Biological Therapy 20:10, pages 1237-1244.
Read now

Articles from other publishers (7)

Fernando Ramírez-Jiménez, Gandhi Fernando Pavón-Romero, Juancarlos Manuel Velásquez-Rodríguez, Mariana Itzel López-Garza, José Fernando Lazarini-Ruiz, Katia Vanessa Gutiérrez-Quiroz & Luis M. Teran. (2023) Biologic Therapies for Asthma and Allergic Disease: Past, Present, and Future. Pharmaceuticals 16:2, pages 270.
Crossref
Garry M. Walsh. 2023.
Andrew Menzies-Gow, Flavia L. Hoyte, David B. Price, David Cohen, Peter Barker, James Kreindler, Maria Jison, Christopher L. Brooks, Peggy Papeleu & Rohit Katial. (2022) Clinical Remission in Severe Asthma: A Pooled Post Hoc Analysis of the Patient Journey with Benralizumab. Advances in Therapy 39:5, pages 2065-2084.
Crossref
Stephanie Korn, Arnaud Bourdin, Geoffrey Chupp, Borja G. Cosio, Doug Arbetter, Mihir Shah & Esther Garcia Gil. (2021) Integrated Safety and Efficacy Among Patients Receiving Benralizumab for Up to 5 Years. The Journal of Allergy and Clinical Immunology: In Practice 9:12, pages 4381-4392.e4.
Crossref
Misa Kusumoto & Bryan J. Mathis. (2021) Biologic Treatments for Asthma and Chronic Obstructive Pulmonary Disorder. Allergies 1:2, pages 92-107.
Crossref
Hiroki Kagoshima, Ryusuke Hori, Tsuyoshi Kojima, Yusuke Okanoue, Atsushi Taguchi, Hirotaka Yamamoto, Koki Hasebe & Kazuhiko Shoji. (2020) Successful treatment of eosinophilic chronic rhinosinusitis and eosinophilic otitis media using the anti-IL-5 receptor monoclonal antibody benralizumab: A case report. Respiratory Medicine Case Reports 30, pages 101135.
Crossref
Giuseppe Guida & Anna Maria Riccio. (2019) Immune induction of airway remodeling. Seminars in Immunology 46, pages 101346.
Crossref

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.